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Ergothioneine is an amino-acid betaine derivative of histidine that was
discovered more than one century ago. Despite significant research pointing
to a function in oxidative stress defence, the exact mechanisms of action of
ergothioneine remain elusive. Although both humans and bacterial pathogens
such as Mycobacterium tuberculosis seem to depend on ergothioneine, humans
are devoid of the corresponding biosynthetic enzymes. Therefore, its biosyn-
thesis may emerge as potential drug target in the development of novel
therapeutics against tuberculosis. The recent identification of ergothioneine-
biosynthetic genes in M. smegmatis enables a more systematic study of its
biology. The pathway is initiated by EgtD, a SAM-dependent methyltransferase
that catalyzes a trimethylation reaction of histidine to give N(),N(),N()-
trimethylhistidine. Here, the recombinant production, purification and crystal-
lization of EgtD are reported. Crystals of native EgtD diffracted to 2.35 A˚
resolution at a synchrotron beamline, whereas crystals of seleno-l-methionine-
labelled protein diffracted to 1.75 A˚ resolution and produced a significant
anomalous signal to 2.77 A˚ resolution at the K edge. All of the crystals belonged
to space group P212121, with two EgtD monomers in the asymmetric unit.
1. Introduction
N(),N(),N()-Trimethyl-2-thiohistidine is a ubiquitous small
metabolite found in all kingdoms of life (1; Fig. 1), with the potential
exception of archaea. This compound was discovered in ergot fungi
and was therefore named ergothioneine (Tanret, 1909). Since then,
ergothioneine has been isolated from human tissue (Melville et al.,
1957), plants, including important foodstuffs, fungi and mycobacteria
(Genghof, 1970) as well as cyanobacteria (Pfeiffer et al., 2011). The
identification of ergothioneine-biosynthetic genes revealed that
ergothioneine is in fact biosynthesized by a broad range of bacteria,
most sequenced basidomycetes, some ascomycetes and even by
several plants (Seebeck, 2010). Humans absorb ergothioneine from
their diet and maintain up to millimolar concentrations in specific
tissues such as kidney, liver and the central nervous system (Hartman,
1990). Key to this inhomogeneous distribution is probably the
ergothioneine-specific transporter protein OCTN1 (Gru¨ndemann et
al., 2005). The elimination of this protein from cultured HeLa cells
through RNA interference induces oxidative stress (Paul & Snyder,
2010). On the other hand, gain-of-function mutations of this trans-
porter are associated with Crohn’s disease (Peltekova et al., 2004).
These observations suggest that ergothioneine is an important player
in human physiology, but the relationship between cellular ergo-
thioneine levels and health is complex. Ergothioneine seems to
protect the fungus Neurospora crassa from peroxide-induced stress,
even though it is remarkably inert towards peroxides in vitro (Bello
et al., 2012). The fact that human pathogens such as Mycobacterium
tuberculosis biosynthesize and apparently require ergothioneine
opens the possibility that this pathway provides a potential target for
novel chemotherapeutics.
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In order to study the biology of ergothioneine, we recently char-
acterized the biosynthetic gene cluster egtABCDE from M. smeg-
matis (Seebeck, 2010). In vitro reconstitution of the methyl-
transferase EgtD, the sulfoxide synthase EgtB and the amido-
hydrolase EgtC demonstrated their central role in thiohistidine
biosynthesis (Fig. 1). EgtD catalyzes the first, committing step by
transferring three methyl groups from three equivalents of
S-adenosylmethionine (SAM) to the -amino group of histidine. The
resulting histidine betaine (2; Fig. 1) is the preferred substrate of
EgtB, which does not act on histidine directly. Deletion of egtD in
M. smegmatis abolishes ergothioneine biosynthesis (Sao Emani et al.,
2013), suggesting that EgtD is a valid target to sabotage ergothio-
neine biosynthesis in vivo.
Although SAM-dependent methyltransferases constitute a well
characterized class of enzymes (Gana et al., 2013; Martin &McMillan,
2002), the EgtD sequence, previously annotated as domain of
unknown function 2260 (DUF2260), does not fit well to any known
methyltransferase. The closest EgtD homologue with known function
is EasF (24% sequence identity to EgtD), which catalyzes the N()-
methylation of dimethylallyl tryptophan in ergot alkaloid biosynth-
esis in Claviceps species (3 and 4; Supplementary Fig. S11; Lorenz et
al., 2007). However, this enzyme has not yet been crystallized. With
a sequence identity of 16%, the closest structurally characterized
homologue is the human methyltransferase Ad-003 (PDB entry 2ex4;
Structural Genomics Consortium, unpublished work), which in turn
belongs to a family of enzymes that catalyze the dimethylation of
ribosomal proteins at N-terminal proline residues (Webb et al., 2010).
As a first step on the path to understanding bacterial ergothioneine
production, we address the structure–function relationships of its
producing enzymes. To unveil the role of EgtD in ergothioneine
biosynthesis and at the same time characterize the structure of
DUF2260-type proteins for the first time, we produced EgtD from
M. smegmatis in Escherichia coli and crystallized the purified protein
using the following methodology.
2. Materials and methods
2.1. Production of recombinant EgtD
The open reading frame of egtD (UniProtKB entry EGTD_
MYCS2) was amplified from M. smegmatis genomic DNA (strain
ATCC 607; DSMZ 43465). The forward primer (50-GCGCATATGG-
CGCTCTCACTGGCCAACTACCTA-30) includes an NdeI restric-
tion site (bold) and the reverse primer (50-GCGCTCGAGTCAC-
CGCACCGCCAGCGACAACCs-30) contains an XhoI restriction
site (bold) and a stop codon (italics). After restriction, the gene was
cloned into the modified pET-19b vector pET19m (Novagen)
digested with the same enzymes. Cloning resulted in an EgtD fusion
construct with an N-terminal His6 tag followed by a TEV (Tobacco
etch virus) protease cleavage site and was checked by DNA
sequencing (the full sequence of the pET19m_His6-TEV-EgtD
construct is mghhhhhhaENLYFQ|GHMALSLANYLAADSAAEA-
LRRDVRAGLTAAPKSLPPKWFYDAVGSDLFDQITRLPEYYP-
TRTEAQILRTRSAEIIAAAGADTLVELGSGTSEKTRMLLDA-
MRDAELLRRFIPFDVDAGVLRSAGAAIGAEYPGIEIDAVCG-
DFEEHLGKIPHVGRRLVVFLGSTIGNLTPAPRAEFLSTLADT-
LQPGDSLLLGTDLVKDTGRLVRAYDDAAGVTAAFNRNVL-
AVVNRELSADFDLDAFEHVAKWNSDEERIEMWLRARTAQ-
HVRVAALDLEVDFAAGEEMLTEVSCKFRPENVVAELAEAG-
LRQTHWWTDPAGDFGLSLAVR, where lower-case letters indi-
cate the affinity tag and italic letters and | indicates the TEV protease
cleavage site).
Heterologous expression of EgtD employed E. coli BL21(DE3)
cells in LB medium supplemented with 100 mg ml1 ampicillin. The
cells were grown to an OD600 of 0.8 and were then induced with
0.5 mM IPTG for 16 h at 293 K. The cells were harvested by centri-
fugation, resuspended in buffer A (300 mM NaCl, 50 mM Na2HPO4
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Figure 1
Biosynthesis of ergothioneine (1) from histidine requires S-adenosylmethionine (SAM), -glutamylcysteine and atmospheric oxygen as co-substrates and is catalyzed by
EgtABCDE. In the first step, the SAM-dependent methyltransferase EgtD catalyzes histidine-betaine synthesis (2).
1 Supporting information has been deposited in the IUCr electronic archive
(Reference: NO5051).
pH 8.0) and lysed by sonication. After centrifugation for 1 h at
48 000g, the protein was purified using Ni2+–NTA Agarose beads
(Qiagen) by washing the beads with buffer A containing 10 mM
imidazole followed by elution with buffer A supplemented with
250 mM imidazole. Cleavage of His6-tagged EgtD with recombinant
His6-tagged TEV protease proceeded in a dialysis bag (cutoff
10 kDa) against 20 mM Tris–HCl, 150 mM NaCl pH 7.5 overnight at
277 K. After the removal of precipitated proteins from the dialysate,
uncleaved EgtD and TEV were separated in a second purification
with Ni2+–NTA Agarose (Qiagen). The tag-removed EgtD was
concentrated and loaded onto a size-exclusion chromatography
column (Superdex 75 26/60, GE Healthcare) equilibrated in the same
buffer. EgtD eluted with a retention volume of 170 ml, which
suggested it to be a monomer in solution (calculated molecular
weight of 35.2 kDa). This was confirmed by analytical size-exclusion
experiments using an S200 10/300 GL column (GE Healthcare;
Supplementary Fig. S2). Purified EgtD was concentrated to
25 mg ml1 (calculated "280 = 36 440M
1 cm1), flash-frozen in liquid
nitrogen and stored at 193 K if not used immediately.
Production of seleno-l-methionine-labelled EgtD was achieved by
cultivation of E. coli BL21(DE3)-RIL cells in artificial medium
suppressing l-methionine biosynthesis (LeMaster & Richards, 1985)
and with buffers containing 5 mM -mercaptoethanol. To yield purer
protein in the first affinity-chromatography step, a Ni2+ HiTrap
Chelating HP column connected to an A¨KTAprime system (GE
Healthcare) was used to allow elution of EgtD in a continuous
gradient of 10–250 mM imidazole. Further purification steps were
performed as for the native protein. The identity of the proteins and
the incorporation of seleno-l-methionine were confirmed by ESI
mass-spectrometric analysis.
2.2. Crystallization
Initial crystallization conditions of tag-removed EgtD (in 20 mM
Tris–HCl pH 7.5, 150 mM NaCl) were determined by the sitting-drop
vapour-diffusion method with The JCSG Core Suites I–IV, The PACT
Suite and The PEGs Suite (Qiagen). Screens were set up in a 96-well
plate at 293 K using a dispensing robot (Mosquito, TTP Labtech).
The drops consisted of 100 nl protein solution and 100 nl reservoir
solution equilibrated against 40 ml reservoir solution. The protein was
screened at three different concentrations (20, 15 and 10 mg ml1).
Crystals of different morphology appeared with various precipitants,
which were optimized with respect to pH and component concen-
trations. A hanging drop set up in 24-well plates was used for opti-
mization of the initial hits. The final condition for the native protein
consisted of 0.5 ml protein solution at 20 mg ml1 EgtD mixed with
0.5 ml reservoir [16–18%(w/v) PEG 8000, 20%(w/v) glycerol, 0.16M
magnesium acetate, 0.08M sodium cacodylate pH 6.2–6.7] equili-
brated against 500 ml reservoir solution. Crystals of the seleno-l-
methionine-labelled protein were obtained by changing the buffer
to MES but keeping the composition of the crystallization solution
otherwise similar [18%(w/v) PEG 8000, 20%(w/v) glycerol, 0.08M
MES pH 6.3, 0.16M magnesium acetate]. High-quality crystals
appeared overnight and no differences in crystallization behaviour
were observed between fresh and frozen protein.
2.3. Data collection and processing
The crystals were flash-cooled in liquid nitrogen for data collection
without additional cryoprotecting agents and tested at an X-ray home
source at 100 K using a copper rotating anode ( = 1.54 A˚) and a
MAR345 image-plate detector (MAR Research). Well diffracting
crystals were sent to beamline PXII of the SLS (Swiss Light Source at
the Paul Scherrer Institute, Villigen, Switzerland) for data collection.
A native data set was collected at a wavelength of 0.9830 A˚ as 1000
non-overlapping 0.25 frames using a Pilatus 6M detector (Dectris).
Since molecular replacement using BALBES (Long et al., 2008) was
not successful for this native EgtD data set, diffraction data were
collected from seleno-l-methionine-labelled crystals of EgtD at
100 K using the same setup. The wavelength was set to 0.9786 A˚ to
collect data at the Se K edge (12.659 keV). A single anomalous
dispersion (SAD) data set was collected from the seleno-l-methio-
nine-labelled protein crystal as 1440 non-overlapping 0.25 frames. A
fluorescence scan was not performed. The data set was indexed and
integrated with XDS (Kabsch, 2010) and scaled using AIMLESS
(Evans, 2006, 2011) in the CCP4 suite (Winn et al., 2011). To deter-
mine the anomalous cutoff of the data, phenix.xtriage from the
PHENIX package was used (Zwart et al., 2005; Adams et al., 2011).
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Table 1
Data-collection and processing statistics.
Values for the highest resolution shell are given in parentheses. All data were collected on
beamline PXII at the Swiss Light Source, Paul Scherrer Institute, Villigen, Switzerland.
Data set Se-SAD† Se Native
Wavelength (A˚) 0.9786 0.9786 0.9830
Resolution range (A˚) 48.72–2.77
(2.92–2.77)
48.72–1.75
(1.78–1.75)
49.1–2.35
(2.43–2.35)
Space group P212121 P212121 P212121
Unit-cell parameters
a (A˚) 71.8 71.8 71.8
b (A˚) 75.5 75.5 76.9
c (A˚) 138.7 138.7 139.0
 =  =  () 90.0 90.0 90.0
Mosaicity‡ () 0.115 0.115 0.061
Completeness (%) 99.1 (98.6)† 97.4 (95.8) 100 (100)
Total No. of reflections 250555 (39024) 1013484 (57635) 302720 (30322)
No. of unique reflections 19504 (2761) 74528 (3977) 32867 (3182)
Multiplicity 6.9 (7.4)† 13.6 (14.5) 9.2 (9.5)
Mean I/(I) 43.6 (28.1)§ 18.8 (2.5) 10.2 (2.5)
Ranom} (%) 2.7 — —
Rmerge†† (%) 5.4 (9.1) 10.6 (127.6) 18.9 (112.8)
Rp.i.m‡‡ (%) 1.9 (3.3) 3.0 (34.5) 6.5 (38.1)
Overall B factor from
Wilson plot (A˚2)
18.8 19.3 20.1
† Friedel mates were treated as separate reflections. ‡ Mosaicity values as reported by
XDS (Kabsch, 2010). § The data were cut at mean I/(I) = 28.1 in the highest
resolution shell because the anomalous signal is significant to 2.77 A˚ resolution
according to phenix.triage from PHENIX (Zwart et al., 2005; Adams et al.,
2011). } Ranom =
P
hkl jhIðþhþ kþ lÞi  ðh k lÞij=
P
hklhIðhklÞi. †† Rmerge =P
hkl
P
i jIiðhklÞ  hIðhklÞij=
P
hkl
P
i IiðhklÞ, where Ii(hkl) is the intensity of the
ith observation of the reflection with index hkl. ‡‡ Rp.i.m. =P
hklf1=½NðhklÞ  1g1=2
P
i jIiðhklÞ  hIðhklÞij=
P
hkl
P
i IiðhklÞ, where N(hkl) is the
number of observations of the reflection with index hkl (Weiss, 2001).
Figure 2
Crystal of native EgtD.
Using HKL2MAP, extraction of the anomalous signal was achieved
with SHELXC and Se atoms were located with SHELXD (Schneider
& Sheldrick, 2002; Pape & Schneider, 2004; Sheldrick, 2010). Details
of the data-collection and processing statistics can be found in
Table 1.
3. Results and discussion
Methyl-group transfer is an important post-translational modification
of various proteins, but also occurs in DNA, RNA and small
molecules. In most cases, one or two methyl groups are transferred,
whereas EgtD is one of the few crystallized enzymes that catalyze the
transfer of three methyl groups to the same substrate. In proteins,
trimethylation is catalyzed, for example, by diphthine synthases,
which trimethylate a pre-modified histidine in the translation elon-
gation factor 2 (EF-2) precursor (Kishishita et al., 2008; Moehring
et al., 1984). Although the diphthine synthases and EgtD catalyse
somewhat similar reactions, the two enzymes share no discernable
sequence homology. In contrast to diphthine synthases, which are
homodimers, EgtD elutes as a monomer from size-exclusion chro-
matography columns. The retention time and apparent molecular
weight of EgtD perfectly agree with the calculated molecular weight
(MWcalc) of 35.2 kDa (Supplementary Fig. S2).
The purification yield was 25 mg native EgtD and 4.5 mg seleno-l-
methionine-labelled EgtD from 1 l of culture, respectively. Verifica-
tion of selenium incorporation using ESI mass spectrometry resulted
in a 234 Da shift with respect to native EgtD. This demonstrates
that all five methionine residues have been labelled with seleno-l-
methionine.
In the initial crystallization condition of native EgtD (as indicated
in x2.2), rod-shaped crystals appeared overnight and were optimized
with respect to pH and precipitant concentration. Furthermore, the
initial condition was successfully used with the seleno-l-methionine-
labelled EgtD. In additional optimization rounds, the cacodylate
buffer was replaced with a variety of organic buffer substances to
avoid interference with the anomalous signal of selenium. All
conditions yielded crystals of 200  30  30 mm in size (Fig. 2).
Additional cryoprotection of EgtD crystals was not required since the
reservoir solution contained sufficient concentrations of precipitants.
Initially, we collected a native data set for EgtD. Indexing and
integration with XDS (Kabsch, 2010) revealed that the investigated
EgtD crystals belonged to space group P212121, suggesting the
presence of two EgtD molecules in the asymmetric unit (solvent
content 52.5%). None of the methyltransferase structures available in
the PDB allowed structure solution of EgtD by molecular replace-
ment, even using the molecular-replacement engine BALBES (Long
et al., 2008). We therefore initiated experimental phasing by produ-
cing seleno-l-methionine-labelled EgtD. These crystals diffracted
better than those obtained with the unlabelled protein, allowing data
collection to 1.75 A˚ resolution. Analysis with phenix.xtriage from the
PHENIX package (Zwart et al., 2005; Adams et al., 2011) detected a
significant anomalous signal to 2.77 A˚ resolution. A Patterson search
with SHELXD (Schneider & Sheldrick, 2002) located the positions of
ten anomalous scatterers, as expected for two EgtD monomers in the
asymmetric unit (Supplementary Fig. S3), yet not all of the self-
vectors of these atoms can be unambigously identified in the Harker
sections of the anomalous Patterson difference map, most likely
owing to the presence of additional cross-vectors (Fig. 3). We are
currently using these data for initial phase determination and will
report the structure elsewhere.
The authors are indebted to R. S. Goody, who enabled the initia-
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Figure 3
Harker sections of an anomalous difference Patterson map calculated from the Se-SAD data reported in Table 1. The map cutoff was set to 2. Numbers indicate the
expected peaks (self-vectors) deduced from the positions of the ten anomalous scatterers located with SHELXD (Supplementary Fig. S3). Coloured lines indicate the
corresponding Harker vectors of three anomalous scatterers that can immediately be deduced from this plot.
(Heidelberg and Dortmund, Germany) for help with data collection
and S. Gentz for assistance with ESI mass spectrometry. The Swiss
Light Source (Paul Scherrer Institute, Villigen, Switzerland) is
acknowledged for providing generous access to their beamlines. This
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